The promise of a revolutionary gene-editing technology is beginning to be realized in experiments aimed at curing sickle cell disease.
Scientists reported Wednesday that they used the CRISPR-Cas9 system to correct a tiny genetic mutation that causes the blood disease, which affects millions of...
via L.A. Times - Science http://ift.tt/2egqy0y
No comments:
Post a Comment